A5077862274- Advanced Radiotherapy Techniques
- Lung Cancer Diagnosis and Treatment
- Radiomics and Machine Learning in Medical Imaging
- Management of metastatic bone disease
- Prostate Cancer Diagnosis and Treatment
- Veterinary Equine Medical Research
- Prostate Cancer Treatment and Research
- Cardiac Valve Diseases and Treatments
- Lung Cancer Treatments and Mutations
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Cardiovascular Conditions and Treatments
- Medical Imaging Techniques and Applications
- Hepatocellular Carcinoma Treatment and Prognosis
- Head and Neck Cancer Studies
- Animal Virus Infections Studies
- CNS Lymphoma Diagnosis and Treatment
- Salivary Gland Tumors Diagnosis and Treatment
- Cancer Genomics and Diagnostics
- Neuroendocrine Tumor Research Advances
- Cancer Treatment and Pharmacology
- Transplantation: Methods and Outcomes
- Ocular Oncology and Treatments
- Bone Tumor Diagnosis and Treatments
- Pleural and Pulmonary Diseases
- Coccidia and coccidiosis research
Sapienza University of Rome
2018-2024
Ospedale Santa Maria Goretti
2023
University of Turin
2020
National Center for Oncological Hadrontherapy
2017-2018
Extranodal NK/T-cell lymphoma, nasal type (ENKTCL-NT), is an aggressive malignancy primarily affecting the sinonasal region, with a strong association Epstein-Barr virus (EBV) infection. The disease significantly more prevalent in Asian and Latin American populations. Diagnosis particularly challenging nonendemic regions. We present case of 78-year-old male one-year history lesions, later diagnosed ENKTCL-NT. patient was treated curative-intent radiotherapy, achieving complete clinical...
The loco regional relapse is frequent in the lung disease. aim of this study was to evaluate outcomes re-irradiation by SBRT terms Local Control (LC) and toxicities. From April 2011 December 2016, twenty-two patients received a SBRT. Twenty- seven lesions were treated. medium BED(10) 100.6 Gy (range: 48–151.2 Gy) EQD2(10) 93.8 40–126 Gy). In previous treatment 97.2 40–120 Gy), 81 32.5–100 median time between first second 18 months. reached out 27 (66%) re-irradiated lesions, with rates 67...
Background/Aim: The aim of this study was to investigate the treatment outcomes and toxicities in patients with liver disease treated by Stereotactic Body Radiation Therapy (SBRT). Patients Methods: From 2007 2016, 43 58 lesions (6 primary 37 metastatic tumors) were SBRT. Results: Local Control reached 47 out (81%) 12 24-month rates 81% 74% respectively. progression-free survival at 24 months 42% 36%, specific 46% Median overall (OS) 20 OS Toxicity very low consisting mainly Grade 1 2....
Lymph node metastases (NMs) are a common site of tumor spread that can occur at different times the disease. Stereotactic body radiation therapy (SBRT) be therapeutic option for treatment NMs in setting oligometastatic disease (OMD). The aim this study was to evaluate as primary end points local control (LC) and secondary locoregional nodal (LRNC), distant (DNC), metastasis-free survival (DMFS), progression-free (PFS), overall (OS), concurrently assess predictive factors response.This is...
700 Background: The standard of care for locally advanced rectal cancer (RC) is neoadjuvant chemoradiotherapy (CRT) with 5FU aimed to tumor downstaging prior radical resection but there a wide spectrum responses it, from none complete. aim this project validate top candidate genes previously identified by microarray studies as prognostic and predictive classifiers RC, using the NanoString nCounter Platform. Methods: Two cohorts RC patients were according regression grade (TRG) AJCC Staging...
Skull-base chordomas are rare and malignant tumors that originate from remnants of the chorda dorsalis (notochord). Adjuvant radiotherapy (RT) is an important predictor improved progression-free survival it recommended after surgery. Exclusive RT represents treatment choice for unresectable chordomas. Particle provides dosimetric advantages higher biological effective dose especially radioresistant tumors. The aim study was to evaluate local control (LC) toxicity profile patients (pts) with...